Abstract:Objective To study the efficacy of the combination of 10μg yeast-recombinated hepatitis B vaccine (HepB) and hepatitis B immunoglobulin (HBIG) administrated to infants born to hepatitis B surface antigen (HBsAg)-positive mothers.Methods Investigation on blocking HBV mother-to-child transmission of children born to HBsAg-positive mothers with a combination of HBIG and 10μg HepB was conducted in Haidian District,Beijing,2013-2015.Data,including demographic information,the status of mother's hepatitis B e antigen (HBeAg) before delivery,and information of vaccination,such as the time of HBIG and of HepB,the type of hospital of birth,the dosage of HBIG,et al,were collected through questionnaires.5 ml blood samples of the children's were collected and then separated into the serum.Serological samples were tested for antibody to HBsAg (anti-HBs),HBsAg,and antibody to hepatitis B core antigen (anti-HBc).The positive rates of HBsAg,anti-HBc and anti-HBs were calculated and compared for different children.Results A total of 377 children born to HBsAg-positive mothers were included.Of these children,344 (91.25％) was positive for anti-HBs,33 (8.75％) was negative for antiHBs.The univariate analysis showed the positive rate of anti-HBs was significantly different for the children with the intervals between the time of administration of HepB3 and blood samples collected (x2 for corrected =30.432,P ＜ 0.001).The multiple logistic analysis showed children administrated different doses of HBIG (P =0.018) and with the intervals between the time of administration of HepB3 and blood samples collected (P ＜ 0.001) were significantly associated the anti-HBs positive or not.Compared with the children administrated 100IU HBIG,the children administrated 200IU HBIG were significantly less likely positive for anti-H Bs (OR =0.352,95 ％ CI:0.148 ～ 0.834).And compared with the children with the intervals between the time of blood sampled and administration of HepB3 ＜ 3 years,children with the intervals ≥ 3 years were significantly less likely positive for anti-HBs (OR =0.119,95％ CI:0.054 ～ 0.262).Conclusion Combination of HBIG and 10 μg HepB can effectively block mother-to-child transmission of HBV for children born to HBsAg-positive mothers.The levels of antiHBs declined over time,particularly 3 years after the administration of HepB3.Postvaccination serologic testing for infants born to HBsAg-positive mothers,especially for both HBsAg-and HBeAg-positive mothers,is important to determine the status of the infants for HBV biomarker,and for the HepB booster.

The 13-year-lasting efficacy of yeast-derived hepatitis B vaccines among the newborns

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

An observation on the long-term efficacy of recombinant hepatitis B vaccines among the newborns

[Long-Term Efficacy of Vaccination Against Hepatitis B in Newborns: 13 Years' Follow-Up].

[Long-Term Efficacy Study of Hepatitis B Vaccination in Newborns--results of 11 Years' Follow-Up].

Evaluation on 16-years immune efficacy of two kinds of hepatitis B vaccines among newborns in Huangpu District of Shanghai

Long-term Efficacy of Infant Hepatitis B Immunization Program

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.

Long-term Evaluation of Immune Efficacy among Newborns 16 Years after HBV Vaccination

The long-term efficacy of recombinant hepatitis B vaccines for children

[Valuation on the Immunization Efficacy on the 23 Years Who Had Received Plasma-Derived HBV Vaccine As Newborns].

Long-term Protection of Infants Against Hepatitis B by Neonatal Immunoprophylaxis Born from Mothers Infected with Hepatitis B Virus

[Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine]

Long-term Effect of Plasma-derived Vaccine in the Prevention of Hepatitis B (eighteen Years'Follow-up Study)

The antibody persistence after immunisation with hepatitis B vaccine combined with different doses of hepatitis B immunoglobulin among infants born by HBsAg positive mothers: a three-year following-up study

Influencing factors of high immune response in newborns induced by hepatitis B vaccine in Haidian District, Beijing

Evaluation of Hepatitis B Vaccination with Different Dose on Blocking Mother-to-child Transmission

The Immune Effect of Blood-borne Hepatitis B Vaccine 20 Years after Vaccination

Efficacy and related factors of hepatitis B immunoglobulin and hepatitis B vaccination in blocking mother-to-child transmission of HBV among 377 children

The One Year Effects of Three Doses of Hepatitis B Vaccine As a Booster in Anti-Hbs-negative Children 11–15 Years after Primary Immunization; China, 2009–2011